Marc Ferrante, MD

University Hospitals Leuven, Belgium

Poster(s):

• P3560 - Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Non-Complicated Crohn’s Disease: Results from the EVOLVE Expansion Study
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT